Skip to main content

Table 2 Comparison of patients’ characteristics and morbidity/ mortality against hypertensive status

From: Morbidity and mortality outcomes of COVID-19 patients with and without hypertension in Lagos, Nigeria: a retrospective cohort study

Variable

Hypertensive(n(%))

X2

P-value

Yes

No

Total

Age (in years)

   

457.47c

0.001

 < 40

33 (8.9)

983 (57.8)

1016 (49.1)

  

 40–49

96 (26.0)

429 (25.2)

525 (25.4))

  

 50–59

118 (32.0)

203 (11.9)

321 (15.5)

  

 > −60

122 (33.1)

87 (5.1)

209 (10.1)

  

Total

369 (100.0)

1702 (100.0)

2071 (100.0)

  

Median age (IQR)

55 (47–63)

37 (30–45)

40 (32–50)

  

Mean ± SD

55.62 ± 12.9

38.68 ± 11.5

41.72 ± 13.4

t = 23.3

0.001

Sex

   

0.47

0.492

 Male

251 (68.0)

1126 (66.2)

1377 (64.5)

  

 Female

118 (32.0)

576 (33.8)

694 (33.5)

  

Total

369 (100.0)

1702 (100.0)

2071 (100.0)

  

Severity on admission

   

159.87c

< 0.001

 Mild

136 (36.9)

1043 (61.3)

1179 (56.9)

  

 Moderate

155 (42.0)

588 (34.5)

743 (35.9)

  

 Severe

53 (14.4)

54 (3.2)

107 (5.2)

  

 Critical

25 (6.8)

17 (1.0)

42 (2.0)

  

Total

369 (100.0)

1702 (100.0)

2071 (100.0)

  

Time till endpoint

   

5.24c

0.022

 < 14 days

197 (66.1)

860 (59.8)

1057 (60.9)

  

 14–28

100 (33.6)

557 (38.7)

657 (37.8)

  

 > 28 days

1 (0.3)

22 (1.5)

23 (1.3)

  

Total

298 (100.0)

1439 (100.0)

1737a(100.0)

  

Median time (IQR)

12 (8–14)

13 (10–14)

   

Mean ± SD

11.06 ± 5.47

12.4 ± 4.91

   

Discharge status determined

   

95.70

< 0.001

 Died

41 (13.7)

32 (2.2)

73 (4.2)

  

 Recovered

247 (82.3)

1391 (96.7)

1638 (94.2)

  

 Transferred out/evacuated

12 (4.0)

16 (1.1)

28 (1.6)

  

Total

300 (100.0)

1439 (100.0)

1739b(100.0)

  
  1. aMissing = 334(16.1%) b
  2. cChi-square test for trend